252 related articles for article (PubMed ID: 24457408)
1. Sequential treatment with teriparatide and strontium ranelate in a postmenopausal woman with atypical femoral fractures after long-term bisphosphonate administration.
Lampropoulou-Adamidou K; Tournis S; Balanika A; Antoniou I; Stathopoulos IP; Baltas C; Triantafillopoulos IK; Papaioannou NA
Hormones (Athens); 2013; 12(4):591-7. PubMed ID: 24457408
[TBL] [Abstract][Full Text] [Related]
2. Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
Greenspan SL; Vujevich K; Britton C; Herradura A; Gruen G; Tarkin I; Siska P; Hamlin B; Perera S
Osteoporos Int; 2018 Feb; 29(2):501-506. PubMed ID: 29085957
[TBL] [Abstract][Full Text] [Related]
3. Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide.
Carvalho NN; Voss LA; Almeida MO; Salgado CL; Bandeira F
J Clin Endocrinol Metab; 2011 Sep; 96(9):2675-80. PubMed ID: 21752890
[TBL] [Abstract][Full Text] [Related]
4. A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate.
Nguyen HH; Milat F; Ebeling PR
Bone Rep; 2017 Jun; 6():34-37. PubMed ID: 28377979
[TBL] [Abstract][Full Text] [Related]
5. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y
J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287
[TBL] [Abstract][Full Text] [Related]
6. Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.
Starr J; Tay YKD; Shane E
Curr Osteoporos Rep; 2018 Aug; 16(4):519-529. PubMed ID: 29951870
[TBL] [Abstract][Full Text] [Related]
7. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures.
Righetti M; Wach J; Desmarchelier R; Coury F
Joint Bone Spine; 2018 May; 85(3):365-367. PubMed ID: 29246529
[TBL] [Abstract][Full Text] [Related]
8. Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
Ramchand SK; Chiang CY; Zebaze RM; Seeman E
Osteoporos Int; 2016 Feb; 27(2):821-5. PubMed ID: 26458389
[TBL] [Abstract][Full Text] [Related]
9. Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.
Zhang HY; Weng HL; Li M; Zhang J
Osteoporos Int; 2019 Nov; 30(11):2349-2354. PubMed ID: 31428823
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
[TBL] [Abstract][Full Text] [Related]
11. Conservative treatment of recurrent symptoms of an incomplete, atypical femoral fracture associated with glucocorticoid, bisphosphonate, and denosumab therapy in a patient with chronic obstructive pulmonary disease.
Lai KH; Chiang CY; Yang RS; Yang KC; Wu CC
Acta Clin Belg; 2019 Oct; 74(5):370-374. PubMed ID: 30336748
[No Abstract] [Full Text] [Related]
12. Bisphosphonate long-term treatment related bilateral subtrochanteric femoral fracture. Can teriparatide be useful?
Tarazona-Santabalbina FJ; Aguilella-Fernández L
Aging Clin Exp Res; 2013 Oct; 25(5):605-9. PubMed ID: 24026625
[TBL] [Abstract][Full Text] [Related]
13. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E
Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
[TBL] [Abstract][Full Text] [Related]
14. The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.
Tsuchie H; Miyakoshi N; Iba K; Kasukawa Y; Nozaka K; Dohke T; Kosukegawa I; Aizawa T; Maekawa S; Abe H; Takeshima M; Tomite T; Segawa T; Ouchi K; Kinoshita H; Suzuki M; Yamashita T; Shimada Y
Osteoporos Int; 2018 Dec; 29(12):2659-2665. PubMed ID: 30105400
[TBL] [Abstract][Full Text] [Related]
15. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.
Cross MB; Nam D; van der Meulen MC; Bostrom MP
J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration.
Miller PD; McCarthy EF
Semin Arthritis Rheum; 2015 Apr; 44(5):477-482. PubMed ID: 25312241
[TBL] [Abstract][Full Text] [Related]
17. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
Weil YA; Rivkin G; Safran O; Liebergall M; Foldes AJ
J Trauma; 2011 Jul; 71(1):186-90. PubMed ID: 21610533
[TBL] [Abstract][Full Text] [Related]
18. Responses to Treatment With Teriparatide in Patients With Atypical Femur Fractures Previously Treated With Bisphosphonates.
Watts NB; Aggers D; McCarthy EF; Savage T; Martinez S; Patterson R; Carrithers E; Miller PD
J Bone Miner Res; 2017 May; 32(5):1027-1033. PubMed ID: 28071822
[TBL] [Abstract][Full Text] [Related]
19. The effect of teriparatide on patients with atypical femur fractures: a systematic review and meta-analysis.
Salamah HM; Abualkhair KA; Kamal SK; Mohamed HA; Alkheder A; Farho MA; Mistry D; Elbardesy H
Arch Orthop Trauma Surg; 2024 Mar; 144(3):1091-1106. PubMed ID: 38135789
[TBL] [Abstract][Full Text] [Related]
20. High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
Sato H; Kondo N; Nakatsue T; Wada Y; Fujisawa J; Kazama JJ; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I
Osteoporos Int; 2017 Aug; 28(8):2367-2376. PubMed ID: 28409215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
